Boehringer Ingelheim and King』s College London Join Forces to Progress New Therapeutic Concepts in Major Depressive Disorder and Schizophrenia
INGELHEIM, Germany & LONDON--(BUSINESS WIRE)--Boehringer Ingelheim and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King』s College London today announced a new coll......
